NYQ – Real vaqt narxi. Valyuta: USD
28.74
-1.04 (-3.49%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
28.82
+0.08 (0.26%)
Bozordan keyin: Mar 27, 2026, 7:54 PM EDT
Teva Pharmaceutical Industries Limited Qo'shma Shtatlar, Yevropa, Isroil va xalqaro miqyosda dori-darmonlar va boshqa dori-darmonlar, hamda biofarmatsevtika mahsulotlarini ishlab chiqaradi, marketing qiladi va tarqatadi. U tabletkalari, kapsulalari, in'ektsiyalari, inhalerlari, suyuqliklari, transdermal yamaglari, malhamlari va kremlari kabi turli dozalash shakllarida dori-darmonlarni taklif etadi; parenteral va qattiq dozalash shakllarida steril mahsulotlar, gormonlar, yuqori kuchli dori-darmonlar va sitotoksik moddalar; hamda tibbiy moslamalar va kombinatsiyalangan mahsulotlar bilan dori-darmonlarni taklif etadi. Kompaniya, shuningdek, markaziy asab tizimi (MAS), nafas olish yo'llari va onkologiya sohalariga e'tibor qaratadi. U faol farmatsevtik ingredientlarni, shuningdek, kontraktli ishlab chiqarish xizmatlarini taqdim etadi; va boshqa farmatsevtika kompaniyalari uchun mahsulotlar portfelini taklif qiluvchi litsenziyalash platformasini boshqaradi. Kompaniya, shuningdek, surunkali limfotsitar leykemiyani va indolent B-hujayrali non-Xog'kin limfomasini davolash uchun BENDEKA va TREANDA in'ektsiyalarini; ko'p sklerozning qaytalanish shakllari bilan og'rigan bemorlarni davolash uchun COPAXONE; kattalardagi migrenni oldini olish uchun AJOVY; Guntinton kasalligi bilan bog'liq xoreya va tardiv diskineziya bilan bog'liq neyrodegenerativ va harakat buzilishlarini davolash uchun AUSTEDO; shizofreniyani davolash uchun UZEDY; ProAir RespiClick inhaler kukuni; astmani davolash uchun QVAR RediHaler; uzoq muddatli muskarinik antagonist BRALTUS; CINQAIR/CINQAERO in'ektsiyasi; DuoResp Spiromax budesonide va formoterol kukuni inhaler; va AirDuo RespiClick fluticasone propionate va salmeterol inhaler kukuni taklif etadi. Kompaniya o'zining OTC mahsulotlarini SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max va FLEGAMINA savdo belgilari ostida taklif etadi. Kompaniya MedinCell S.A.; Sanofi; Alvotech; va Biolojic Design Ltd. bilan hamkorlik shartnomalariga, shuningdek MODAG GmbH bilan litsenziya shartnomasiga ega. Kompaniya 1901 yilda tashkil etilgan va Isroilning Tel-Aviv-Yafo shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Eric A. Hughes M.D., Ph.D. | Executive VP of Global R&D and Chief Medical Officer |
| Kathleen Veit | Senior Vice President, Global Compliance & Ethics Officer |
| Mr. Amir Weiss | Senior VP & Chief Accounting Officer |
| Mr. Christopher J. Stevo CFA | Senior Vice President of Investor Relations & Competitive Intelligence |
| Mr. Eliyahu Sharon Kalif | Executive VP & CFO |
| Mr. Kevin C. Mannix | Senior Vice President of Investor Relations |
| Mr. Matthew Shields | Executive Vice President of Global Operations |
| Mr. Placid Jover | Executive VP & CHRO |
| Mr. Richard D. Francis | President, CEO & Director |
| Mr. Richard Gordon Daniell | Executive Vice President of European Commercial |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-02-03 | 10-K | d93612d10k.htm |
| 2026-01-28 | 8-K | f8k_012826.htm |
| 2026-01-12 | 8-K | f8k_011126.htm |
| 2025-12-11 | 8-K | d46386d8k.htm |
| 2025-11-05 | 10-Q | d920125d10q.htm |
| 2025-07-30 | 10-Q | d939815d10q.htm |
| 2025-06-05 | 8-K | d90930d8k.htm |
| 2025-06-02 | SD | d949600dsd.htm |
| 2025-05-28 | 8-K | d918164d8k.htm |
| 2025-05-22 | 8-K | d929611d8k.htm |